Invezz

Exponent (EXPO)

Nasdaq Market Closed

Exponent Inc. is a specialist consulting firm that applies science, engineering, health, and regulatory expertise to complex technical problems. The company is best known for work involving failure analysis, product safety, risk assessment, regulatory support, and litigation-related consulting. Its clients include corporations, insurers, government agencies, law firms, and other organisations that need independent technical analysis.

The company operates mainly through two business areas. Its engineering and other scientific segment is the larger contributor and covers disciplines such as biomechanics, biomedical engineering, materials science, civil engineering, construction consulting, mechanical engineering, electrical engineering, human factors, and accident reconstruction. This work can involve investigating product failures, evaluating infrastructure issues, assessing vehicle or medical device performance, or helping clients understand the technical causes of incidents.

Exponent’s environmental and health segment focuses on areas including chemical regulation, food safety, toxicology, ecological sciences, environmental science, earth sciences, and health risk assessment. This segment supports clients facing regulatory filings, environmental claims, safety reviews, and scientific questions linked to chemicals, consumer products, industrial operations, and public health.

The firm’s business model depends on highly qualified consultants, many with advanced scientific or engineering credentials. Revenue is generated primarily from professional services, with demand driven by product development, regulation, disputes, recalls, accidents, and broader risk-management needs. Exponent generates most of its revenue in the United States, although its expertise can be applied to global matters. Its distinguishing feature is the breadth of technical disciplines it can combine when clients face problems that require rigorous, evidence-based analysis.

59.66 USD
24.16 USD
+0.18 (+0.30%)
After-hours

Last updated

Market Cap
2.89B
P/E
26.49
P/FCF
25.45
P/S
4.9
Enterprise Value
2.77B
Sector
Industrials
Industry
Management Consulting Services
Address
EXPONENT INC, MENLO PARK, CA, 94025
GlobeNewswire Inc.

Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors

Apr 06, 2026, 16:35 PM
Zacks Investment Research

Is Exponent (EXPO) Outperforming Other Business Services Stocks This Year?

Jun 13, 2024, 09:40 AM
Zacks Investment Research

Are Business Services Stocks Lagging Exponent (EXPO) This Year?

May 28, 2024, 09:40 AM
Zacks Investment Research

Exponent (EXPO) Just Flashed Golden Cross Signal: Do You Buy?

May 20, 2024, 09:55 AM
Zacks Investment Research

Is HNI (HNI) Stock Outpacing Its Business Services Peers This Year?

May 07, 2024, 09:40 AM
Zacks Investment Research

Why Exponent (EXPO) Might be Well Poised for a Surge

Apr 30, 2024, 12:20 PM
Zacks Investment Research

Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates

Apr 25, 2024, 17:35 PM
GlobeNewswire Inc.

Exponent Declares Regular Quarterly Dividend for Q2 2024

Apr 25, 2024, 16:05 PM
GlobeNewswire Inc.

Exponent to Announce First Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on April 25, 2024

Apr 09, 2024, 18:15 PM
GlobeNewswire Inc.

Exponent Increases Quarterly Dividend Payment from $0.26 to $0.28 per Share for Q1 2024, Increases Stock Repurchase Authorization to $100 Million

Feb 01, 2024, 16:05 PM
GlobeNewswire Inc.

Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 01, 2024, 16:05 PM
GlobeNewswire Inc.

Exponent to Announce Fourth Quarter and Fiscal Year 2023 Results and Host Quarterly Conference Call on February 1, 2024

Jan 11, 2024, 16:05 PM
GlobeNewswire Inc.

Exponent to Announce Third Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on October 26, 2023

Oct 05, 2023, 16:05 PM
Zacks Investment Research

Exponent (EXPO) Lags Q2 Earnings and Revenue Estimates

Jul 27, 2023, 17:25 PM
GlobeNewswire Inc.

Exponent to Announce Second Quarter of Fiscal Year 2023 Results and Host Quarterly Conference Call on July 27, 2023

Jul 06, 2023, 16:05 PM
Zacks Investment Research

Mastercard (MA) Unveils MTN to Promote Digital Asset Usage

Jun 29, 2023, 12:04 PM
Zacks Investment Research

Is the Options Market Predicting a Spike in Exponent (EXPO) Stock?

Jun 29, 2023, 08:44 AM
Zacks Investment Research

3 Stocks to Buy on New Analyst Coverage

Jun 29, 2023, 07:47 AM
Zacks Investment Research

Mastercard (MA) Inks MoU to Ease Caribbean Cross-Border Transfers

Jun 14, 2023, 06:19 AM
GlobeNewswire Inc.

Exponent to Present at Upcoming Investor Conferences

May 31, 2023, 16:05 PM
Market Cap
2.89B
Enterprise Value
2.77B
P/E
26.49
P/B
8.53
P/S
4.9
EV / EBITDA
21.81
EV / Sales
4.7
EPS
2.25
Dividend Yield
2.14%
P/FCF
25.45
P/CF
23.37
Free Cash Flow
113.39M
ROE
32.2%
ROA
15.85%
Debt / Equity
0
Current Ratio
2.4
Quick Ratio
2.4
Cash
0.83
Avg Volume
545.97K
Fundamentals Snapshot Price
59.48

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 151.82M 147.43M 147.12M 141.96M 137.44M
Gross profit 151.82M 147.43M 147.12M 141.96M 137.44M
Operating income 41.38M 29.14M 29.04M 17.18M 44.43M
EBITDA 43.89M 31.68M 31.57M 19.7M 46.92M
Net income 29.57M 24.76M 28.04M 26.55M 26.65M
Basic EPS 0.59 0.49 0.55 0.52 0.52
Diluted EPS 0.59 0.49 0.55 0.52 0.52

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 687.38M 777.52M 761.45M 759.43M 763.24M
Total liabilities 349.04M 387.18M 358.59M 331.65M 321.83M
Total equity 338.34M 390.34M 402.86M 427.78M 441.41M
Cash & equivalents 118.55M 221.93M 207.38M 231.8M 245.11M
Current assets 340.89M 427.58M 416.79M 425.65M 432.8M
Current liabilities 142.2M 178M 154.77M 134.97M 130.27M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -975K 55.58M 32.65M 36.22M 7.27M
Investing cash flow -2.45M -2.69M -2.68M -2.27M -1.75M
Financing cash flow -99.68M -38.4M -54.51M -47.47M -20.05M
Change in cash -103.38M 14.55M -24.42M -13.31M -13.79M
Kind Filing Date Link
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — James Bradley A View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Reiss Richard View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index SCHEDULE 13G/A — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Sala Joseph View Filing
form 4 Form 4 — Rakow Joseph View Filing
edgar index 3 — EXPONENT INC View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
edgar index 10-Q — EXPONENT INC View Filing
edgar index SCHEDULE 13G — EXPONENT INC View Filing
edgar index SCHEDULE 13G — EXPONENT INC View Filing
edgar index ARS — EXPONENT INC View Filing
edgar index DEF 14A — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 8-K — EXPONENT INC View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Pye John View Filing
form 4 Form 4 — Pye John View Filing
edgar index SCHEDULE 13G/A — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing